Benzylamine

Benzylamine

SCHEMBL283107

NCc1ccccc1.O=[PH](O)O[PH](=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 6/20 0.58
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
TAAR1 Q96RJ0 2/20 0.45
MAOB P27338 1/20 0.44
ENPP2 Q13822 1/20 0.42
IDO1 P14902 2/20 0.39
CYP2A6 P11509 1/20 0.38
HTR2A P28223 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABAT P80404 1/20 0.38
F10 P00742 1/20 0.38
HTR6 P50406 1/20 0.38
PNMT P11086 1/20 0.38
CFD P00746 3/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzylamine SCHEMBL11406732 0.96 LOXL2 (0.54) LOXL2CYP1A2CYP2D6CYP2C9TSHR
Benzylamine SCHEMBL1766058 0.87 LOXL2 (0.70) LOXL2CYP1A2CYP2D6CYP2C9TSHR
Benzylamine SCHEMBL1061904 0.87 LOXL2 (0.70) LOXL2CYP1A2CYP2D6CYP2C9TSHR
Diphenylmethane SCHEMBL28323947 0.83 CALM1 (0.55) TSHR
Benzyl Alcohol SCHEMBL10856262 0.81 TSHR (0.61) TSHRMAOB
SCHEMBL11530943 0.80 MAOB (0.50) LOXL2CYP1A2CYP2D6CYP2C9CYP2C19
Benzylamine SCHEMBL27699388 0.79 LOXL2 (0.82) LOXL2CYP1A2CYP2D6CYP2C9TSHR
Benzyl Alcohol SCHEMBL10862365 0.79 TSHR (0.58) TSHRMAOB
Benzyl Alcohol SCHEMBL10863064 0.79 TSHR (0.58) TSHRMAOB
(Chloromethyl)Benzene SCHEMBL11339743 0.79 ALDH1A1 (0.39) TSHRMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0953283-B9 Method for production on the spot of a disinfectant peracetic acid system NUOVA FARMEC S R L (IT) 2006-05-03 EP claimed
EP-0953283-B1 Method for production on the spot of a disinfectant peracetic acid system FARMEC S N C DI TABASSO RENATO (IT) 2005-07-06 EP claimed
US-20030211169-A1 Disinfectant peracetic acid system TABASSO RENATO (IT) 2003-11-13 US claimed
US-20020004057-A1 METHOD FOR PRODUCTION ON THE SPOT OF A DISINFECTANT PERACETIC ACID SYSTEM NUOVA FARMEC S.R.L. (IT) 2002-01-10 US claimed
EP-0953283-A1 Method for production on the spot of a disinfectant peracetic acid system Farmec S.n.c. di Tabasso Renato & C. (IT) 1999-11-03 EP claimed
US-4051058-A PERACIDS, HYDROGEN PEROXIDE, A SEQUESTERING PHOSPHONIC ACID, ANIONIC SURFACTANT HENKEL & CIE GMBH (DT) 1977-09-27 US claimed
CN-115605568-B Overbased textile detergents comprising protease 汉高股份有限及两合公司 2025-02-18 CN disclosed
EP-4165158-B1 A DISINFECTANT AND CLEANING COMPOSITION LA SUPERQUIMICA S A (ES) 2023-11-15 EP disclosed
CN-112639066-B Polymer active ingredient with improved detergency 巴斯夫欧洲公司 2023-08-22 CN disclosed
EP-4165158-A1 A DISINFECTANT AND CLEANING COMPOSITION La Superquimica, S.A. (ES) 2023-04-19 EP disclosed
WO-2021250049-A1 A DISINFECTANT AND CLEANING COMPOSITION LA SUPERQUIMICA, S.A. (ES) 2021-12-16 WO disclosed
EP-3922706-A1 A DISINFECTANT AND CLEANING COMPOSITION La Superquimica, S.A. (ES) 2021-12-15 EP disclosed
US-20210140945-A1 METHODS OF TREATING NEUROLOGICAL DISEASES AND DISORDERS MADRIGAL PHARMACEUTICALS INC (US) 2021-05-13 US disclosed
EP-0162510-A1 Kit for use in the treatment of osteoporosis THE PROCTER & GAMBLE COMPANY (US) 1985-11-27 EP disclosed
EP-0147207-A1 Disinfectants Albright & Wilson Limited (GB) 1985-07-03 EP disclosed
US-4308147-A Composition and treating aqueous solutions with N-carboxy alkyl amino alkane polyphosphonic acids and their alkali metal salts BENCKISER-KNAPSACK GMBH (DE) 1981-12-29 US disclosed
US-4307038-A N-Carboxy alkyl amino alkane polyphosphonic acids BENCKISER-KNAPSACK GMBH (DE) 1981-12-22 US disclosed
US-4250107-A WATER SOFTENERS, SEQUESTERING AGENTS BENCKISER-KNAPSACK GMBH (DE) 1981-02-10 US disclosed
US-4216163-A SEQUESTERING AGENTS BENCKISER-KNAPSACK GMBH (DE) 1980-08-05 US disclosed
US-4051058-A PERACIDS, HYDROGEN PEROXIDE, A SEQUESTERING PHOSPHONIC ACID, ANIONIC SURFACTANT HENKEL & CIE GMBH (DT) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020004057-A1 METHOD FOR PRODUCTION ON THE SPOT OF A DISINFECTANT PERACETIC ACID SYSTEM AGPS, AHSA1, CDA LOXL2 4630/4885CYP1A2 734/4885CYP2D6 1274/4885
US-20030211169-A1 Disinfectant peracetic acid system AGPS, AHSA1, HAO2 LOXL2 4547/4885CYP1A2 607/4885CYP2D6 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.